Aquinox Pharmaceuticals Profit Margin 2013-2018 | AQXP

Current and historical gross margin, operating margin and net profit margin for Aquinox Pharmaceuticals (AQXP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Aquinox Pharmaceuticals net profit margin as of December 31, 2018 is 0%.
Aquinox Pharmaceuticals Annual Profit Margins
Aquinox Pharmaceuticals Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.064B $0.025B
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $49.659B 8.94
Teva Pharmaceutical Industries (TEVA) Israel $16.606B 5.73
Mylan (MYL) United Kingdom $14.803B 6.26
Bausch Health Cos (BHC) Canada $8.636B 6.14
Dr Reddy's Laboratories (RDY) India $6.502B 25.93
Supernus Pharmaceuticals (SUPN) United States $1.866B 17.31
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.845B 3.00
Homology Medicines (FIXX) United States $0.967B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.943B 87.65
CymaBay Therapeutics (CBAY) United States $0.709B 0.00
Voyager Therapeutics (VYGR) United States $0.586B 0.00
Assembly Biosciences (ASMB) United States $0.465B 0.00
Akorn (AKRX) United States $0.440B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.366B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.210B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.122B 0.00
Acasti Pharma (ACST) Canada $0.082B 0.00
Agile Therapeutics (AGRX) United States $0.064B 0.00
Teligent (TLGT) United States $0.062B 0.00
Evoke Pharma (EVOK) United States $0.025B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00